Quest Diagnostics Incorporated · NYSE:DGX
Kuppusamy Karthik sold 8,147 Quest Diagnostics Incorporated shares (Form 4)
Traded Jun 4, 2026 · Filed Jun 8, 2026
On Jun 4, 2026, Kuppusamy Karthik (SVP, Clinical Solutions) sold 8,147 Quest Diagnostics Incorporated shares at US$200.00 for US$1.63M under a trading plan, leaving 13,510 shares. Filed Jun 8, 2026 (Form 4).
- Sold
- 8,147 shares
- Price
- US$200.00
- Value
- US$1.63M
- Holding after
- 13,510 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, Clinical Solutions
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Option exercise | 3,320 | US$127.73 | 16,830 | Direct |
| Jun 4, 2026 | Common Stock | Option exercise | 4,827 | US$121.81 | 21,657 | Direct |
| Jun 4, 2026 | Common Stock | Sale | 8,147 | US$200.00 | 13,510 | Direct |
Source
Related
- Quest Diagnostics Incorporated
- Kuppusamy Karthik
- Quest Diagnostics Incorporated shareholders
- Form 4 · Kuppusamy Karthik · Jul 27, 2026
- Form 4 · Kuppusamy Karthik · Apr 24, 2026
- Form 4 · Davis J. E. · Sep 3, 2026
- Form 4 · Prevoznik Michael E · Aug 31, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Form 4 · Delaney Mark E · Jul 29, 2026
- Form 4 · Carter Robert B · Jul 27, 2026